#678137
Galar an chraicinn chnapánaigh
Lumpy skin disease
Galar an chraicinn chnapánaigh
Lumpy skin disease
Galar an chraicinn chnapánaigh
Lumpy skin disease
Iarscríbhinn IX maidir le vacsaíniú in aghaidh ionfhabhtú le galar an chraicinn chnapánaigh (LSD).
Annex IX on vaccination against infection with lumpy skin disease virus (LSD).
Ionfhabhtú le galar an chraicinn chnapánaigh (LSD)
Infection with lumpy skin disease virus (LSD)
Tháinig galar an chraicinn chnapánaigh chun cinn san Aontas den chéad uair in 2015 sa Ghréig.
LSD occurred in the Union for the first time in 2015 in Greece.
a coinníodh ar bhunaíochtaí nach bhfuil suite i gcrios srianta a bunaíodh de bharr galar crúb agus béil a bheith ann, ionfhabhtú le víreas phlá na mbó, ionfhabhtú le víreas fhiabhras Ghleann na Claise, le pliúrainiúmóine tógálach buaibheach nó le galar an chraicinn chnapánaigh nó le galar atá ag teacht chun cinn agus a bhaineann le bó-ainmhithe;”;
were kept on establishments not situated in a restricted zone established due to the occurrence of foot-and-mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia or lumpy skin disease or of an emerging disease relevant for bovine animals;’;
Cinneadh Cur Chun Feidhme (AE) 2019/81 ón gCoimisiún an 17 Eanáir 2019 lena leasaítear Iarscríbhinní I a ghabhann le Cinneadh Cur Chun Feidhme (AE) 2016/2008 i dtaca le bearta rialaithe sláinte ainmhithe maidir le galar an chraicinn chnapánaigh i mBallstáit áirithe, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Decision (EU) 2019/81 of 17 January 2019 amending Annex I to Implementing Decision (EU) 2016/2008 concerning animal health control measures relating to lumpy skin disease in certain Member States is to be incorporated into the EEA Agreement.
Ina theannta sin, chuir an Spáinn an Coimisiún agus an Buanchoiste um Plandaí, Ainmhithe, Bia agus Beatha ar an eolas, in éagmais bearta maolaithe riosca atá dírithe go speisialta ar bholgach caorach agus ar bholgach gabhar in Iarscríbhinn VII a ghabhann le Rialachán Tarmligthe (AE) 2020/687, agus ag feitheamh le leasú ar an Iarscríbhinn sin, go gcuirfidh sí i bhfeidhm na bearta maolaithe riosca a leagtar amach san Iarscríbhinn sin maidir le galar an chraicinn chnapánaigh, maidir le feoil agus bainne ó ainmhithe den chineál gabhair agus den chineál caorach de thionscnamh na gcriosanna cosanta agus faireachais a bhunaítear i gcomhréir leis an Rialachán Tarmligthe sin.
In addition, Spain has informed the Commission and the Standing Committee on Plants, Animals, Food and Feed that in the absence of risk mitigation measures specially aimed at sheep pox and goat pox in Annex VII to Delegated Regulation (EU) 2020/687, and awaiting an amendment to that Annex, it will apply the risk mitigation measures set out in that Annex for lumpy skin disease, to meat and milk from caprine an ovine animas originating from the protection and surveillance zones established in accordance with that Delegated Regulation.
Tá sé ráite ag an Spáinn gur gá di na bearta maolaithe riosca sin a dhéanamh a chuireann san áireamh an chosúlacht idir víreas na bolgaí caorach agus na bolgaí gabhar agus galar an chraicinn chnapánaigh, dhá víreas a bhaineann leis an bhfine Poxviridae agus leis an ngéineas Capripoxvirus.
Spain has stated it needs to take these risk mitigating measures which take into account the similarity between sheep pox and goat pox virus and lumpy skin disease virus, both belonging to the family Poxviridae and genus Capripoxvirus.
COINNÍOLLACHA SONRACHA MAIDIR LE GLUAISEACHTAÍ AINMHITHE AGUS TÁIRGÍ A THOIRMEASC AGUS MAIDIR LE MAOLÚ A DHEONÚ I gCOMHRÉIR LE hAIRTEAGAL 13, I gCRIOSANNA VACSAÍNITHE INA nDÉANTAR VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN GALAR AN CHRAICINN CHNAPÁNAIGH A CHOSC AGUS A RIALÚ
SPECIFIC CONDITIONS FOR THE PROHIBITION OF MOVEMENTS OF ANIMALS AND PRODUCTS AND FOR GRANTING A DEROGATION IN ACCORDANCE WITH ARTICLE 13, IN VACCINATION ZONES WHERE EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD IS CARRIED OUT
Cinneadh Cur Chun Feidhme (AE) 2019/1992 ón gCoimisiún an 27 Samhain 2019 lena leasaítear Cinneadh Cur Chun Feidhme (AE) 2016/2008 i dtaca le bearta rialaithe sláinte ainmhithe maidir le galar an chraicinn chnapánaigh i mBallstáit áirithe trí shíneadh a chur lena thréimhse cur i bhfeidhm, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Decision (EU) 2019/1992 of 27 November 2019 amending Implementing Decision (EU) 2016/2008 concerning animal health control measures relating to lumpy skin disease in certain Member States by prolonging its period of application is to be incorporated into the EEA Agreement.
Is galar veicteoir-iompartha é galar an chraicinn chnapánaigh, arb é is cúis leis víreas ghalar an chraicinn chnapánaigh, galar a bhíonn ar bhó-ainmhithe agus is cúis le caillteanais eacnamaíocha nach beag, laghdú ar an tál bainne, cnaíteacht thromchúiseach, damáiste buan do sheithí, roinnt deacrachtaí tánaisteacha agus éineart ainsealach ar feadh míonna, agus toirmisc thrádála.
Infection with lumpy skin disease (LSD) virus, caused by lumpy skin disease virus (LSDV), is a vector-borne disease of bovine animals that causes substantial economic losses, reduces milk yield, causes severe emaciation, permanent damage to hides, several secondary complications, months-long chronic debility, and incurs trade bans.
Ina theannta sin, maidir leis an gCróit agus an Bhoisnia agus an Heirseagaivéin, tíortha nach raibh buailte le galar an chraicinn chnapánaigh, chuir siad vacsaíniú chun feidhme mar bheart coisctheach, i bhfianaise an galar a bheith ag tarlú i dtíortha comharsanacha.
In addition, Croatia and Bosnia and Herzegovina, that were not affected by LSD, implemented vaccination as a preventive measure, in view of disease occurrence in neighbouring countries.
Ó bhí 2017 ann níor tuairiscíodh aon ráig de ghalar an chraicinn chnapánaigh san Eoraip, cé gur taifeadadh galar an chraicinn chnapánaigh i gcodanna d’Anatóil na Tuirce go dtí 2021 agus cé go bhfuil sé fós i láthair sa Rúis agus á leathadh go fóill san Áise, ag déanamh difear do thíortha i bhfo-ilchríoch na hIndia, san Áise Thoir agus in Oirdheisceart na hÁise.
Since 2017, no LSD outbreaks have been reported in Europe although LSD was recorded until 2021 in parts of Anatolia, Türkiye and remains present in Russia while it continues to spread in Asia, affecting countries of the Indian subcontinent, East Asia and South East Asia.
Agus pleananna vacsaínithe na Bulgáire agus na Gréige le haghaidh 2023, an staid eipidéimeolaíoch a mhéid a bhaineann leis an ngalar sin san Aontas, agus an tréimhse athshlánaithe maidir le galar an chraicinn chnapánaigh a leagtar síos i Rialachán Tarmligthe (AE) 2023/361 á gcur san áireamh, beidh feidhm ag an gCinneadh seo go dtí an 31 Lúnasa 2024,
Taking into account the LSD vaccination plans of Bulgaria and Greece for 2023, the epidemiological situation as regards that disease in the Union, and the recovery period for LSD, as laid down in Delegated Regulation (EU) 2023/361, this Decision should apply until 31 August 2024,
I bhfianaise Rialachán Cur Chun Feidhme (AE) 2021/1070 a bheith imithe in éag, tá sé ríthábhachtach na limistéir a shainítear mar chriosanna vacsaínithe I agus II sa Bhulgáir agus sa Ghréig i ndáil le galar an chraicinn chnapánaigh a liostú, ar criosanna vacsaínithe iad a chomhfhreagraíonn do chriosanna srianta I agus II de Rialachán Cur Chun Feidhme (AE) 2021/1070, agus tá sé ríthábhachtach freisin rialacha breise a leagan síos i ndáil leis na hoibleagáidí ar oibreoirí maidir le deimhnithe sláinte ainmhithe i dtaca le gluaiseachtaí bó-ainmhithe, agus i dtaca le gluaiseachtaí táirgí geirmeacha agus seachtháirgí ainmhithe neamhphróiseáilte uathu, ó chriosanna vacsaínithe I agus II, lasmuigh de na criosanna sin, chun a áirithiú go mbeidh faisnéis sláinte leordhóthanach chruinn le fáil sna deimhnithe sláinte ainmhithe sin agus go mbeidh siad leanúnach leis na bearta a bhí ann roimhe sin.
In view of the expiry of Implementing Regulation (EU) 2021/1070, it is essential to list the areas defined as vaccination zones I and II in relation to LSD, in Bulgaria and Greece, that correspond to the restricted zones I and II of Implementing Regulation (EU) 2021/1070, and to lay down additional rules regarding the operators’ obligations with regard to animal health certificates for movements of bovine animals, as well as those for germinal products and unprocessed animal by-products thereof, from vaccination zones I and II, outside these zones, to ensure that these animal health certificates provide adequate and accurate health information and there is a continuity with the measures previously in place.